|
n
|
lncRNA JPX level†
|
χ2 test
|
P value
|
---|
Characteristics
| |
High
|
Low
| | |
---|
Total cases
|
116
|
58
|
58
| | |
Gender
|
Male
|
66
|
34
|
32
|
0.1406
|
0.7077
|
Female
|
50
|
24
|
26
| | |
Age (years)
|
≤ 60
|
40
|
18
|
22
|
0.6105
|
0.4346
|
>60
|
76
|
40
|
36
| | |
Smoking history
|
Yes
|
47
|
26
|
21
|
0.8942
|
0.3443
|
No
|
69
|
32
|
37
| | |
Histology
|
Adenocarcinoma
|
84
|
41
|
43
|
0.2015
|
0.9042
|
Squamous carcinoma
|
26
|
14
|
12
| | |
Other type
|
6
|
3
|
3
| | |
Tumor location
|
Left
|
55
|
24
|
31
|
1.694
|
0.193
|
Right
|
61
|
34
|
27
| | |
Differentiation
|
High and moderate
|
21
|
11
|
10
|
0.05815
|
0.8095
|
Poor
|
95
|
47
|
48
| | |
Tumor size(cm)
|
≤ 3
|
84
|
34
|
50
|
11.05
|
0.0009**
|
>3
|
32
|
24
|
8
| | |
TNM stage
|
I + II
|
87
|
35
|
52
|
13.29
|
0.0003***
|
III + IV
|
29
|
23
|
6
| | |
- †Median expression level was used as cutoff. Low expression of JPX in 116 patients was defined as a value below the 50th percentile, and high above the 50th percentile. P values were acquired by Pearson’s chi-square test. **P < 0.01, ***P < 0.001